Tel Aviv Stock Exchange Ltd. TASE
TASE · Israel · Finance
ILA 13,920.00+220.00 (+1.61%)
Market open· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Government bond yields are biting into equity valuations and shaking up volatility, yet for global exchange and trading platform operators this storm can also mean more activity on their markets. You do not need to trade interest rates to feel the impact. Order flow, hedging, and portfolio reshuffles all run through these venues. This article unpacks that link and spotlights 3 stocks that look especially exposed to the current rate shock. The stocks highlighted below are only a small sample...
Tel-Aviv Stock Exchange (TASE:TASE) has been added to the FTSE All-World Index in USD, a shift that can draw fresh attention from global index trackers and institutional portfolios. The Tel-Aviv Stock Exchange share price has surged recently, with a 1-day share price return of 14.98% and a 30-day share price return of 28.29% taking it to ₪147.4. The 1-year total shareholder return of 97.09% alongside a very large 5-year total shareholder return near 10x points to strong, building momentum...
Teva Begins Trading Ordinary Shares Directly on the NYSE Teva Pharmaceutical Industries Ltd Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy PARSIPPANY, N.J. and TEL AVIV, Israel, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global biopharmaceutical company, today announced that its ordinary shares will begin trading today directly on the New York Stock Exchange (NYSE) completing the compan
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.